Relmada Therapeutics RLMD
NASDAQ RLMD
$3.21 -0.15 (-4.46%)
At close: Oct 21, 2026 · 4:00 PM EDT

Relmada Therapeutics (RLMD) Preferred Shares (2014 - 2015)

Updated

Relmada Therapeutics (RLMD) reported Preferred Shares of $72.00 for Q1 2016, unchanged from the prior quarter.

Analysis

Relmada Therapeutics (RLMD) Preferred Shares (2014 - 2015) Analysis & Trends

Dating back to Q4 2014, Relmada Therapeutics' Preferred Shares record includes 4 quarters.

  • By year, Preferred Shares came in at $465.00 in FY2014.
  • Five-year quarterly Preferred Shares spans a low of $72.00 in Q4 2015 and a high of $667.00 in Q4 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Relmada Therapeutics 361.29 Mn -197.30 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2015 72.00
Jun 30, 2015 72.00
Mar 31, 2015 465.00
Dec 31, 2014 465.00
Sep 30, 2014 3,337.00
Jun 30, 2014 667.00
API Access

Relmada Therapeutics Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=RLMD&period=max&api_key=YOUR_API_KEY